Cogent Biosciences (NASDAQ:COGT) Now Covered by Scotiabank
Scotiabank assumed coverage on shares of Cogent Biosciences (NASDAQ:COGT – Free Report) in a report issued on Friday morning, Marketbeat Ratings reports. The brokerage issued a sector outperform rating and a $17.00 price objective on the technology company’s stock. COGT has been the subject of several other research reports. Wedbush reaffirmed a “neutral” rating and […]
Scotiabank assumed coverage on shares of Cogent Biosciences (NASDAQ:COGT – Free Report) in a report issued on Friday morning, Marketbeat Ratings reports. The brokerage issued a sector outperform rating and a $17.00 price objective on the technology company’s stock. COGT has been the subject of several other research reports. Wedbush reaffirmed a “neutral” rating and […]
